Downregulated expression of microRNA-124 in pediatric intestinal failure patients modulates macrophages activation by

Yong-Tao Xiao1,2,3, Jun Wang1,3, Wei Lu1

  • 1Department of Pediatric Surgery, Xin Hua Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.

Cell Death & Disease
|December 16, 2016
PubMed

Insights

MicroRNA-124 (miR-124) is crucial for regulating intestinal macrophages. Lower miR-124 levels in intestinal failure (IF) patients increase inflammation, suggesting miR-124 as a potential therapeutic target for pediatric IF.

Area of Science:

  • Immunology
  • Gastroenterology
  • Molecular Biology

Background:

  • Intestinal inflammation is key in intestinal failure (IF) pathogenesis.
  • Intestinal macrophages are vital for gut homeostasis, but their activation mechanisms are unclear.
  • MicroRNAs (miRNAs) regulate immune responses, prompting investigation into miR-124's role.

Purpose of the Study:

  • To investigate the role of miR-124 in intestinal macrophage activation in pediatric IF.
  • To explore miR-124's potential as a therapeutic target for IF-associated inflammation.

Main Methods:

  • Compared miR-124 expression in intestinal macrophages from IF patients and controls.
  • Utilized miRNA fluorescence in situ hybridization to analyze miR-124 levels.
  • Investigated miR-124's targeting of STAT3 and AChE mRNAs.
  • Assessed the impact of miR-124, STAT3, and AChE inhibition on macrophage activation.

Main Results:

  • Intestinal macrophages and inflammatory cytokines (IL-6, TNF-α) were elevated in pediatric IF patients.
  • miR-124 expression was significantly reduced in IF patients' intestinal macrophages.
  • Overexpression of miR-124 attenuated IL-6 and TNF-α production.
  • miR-124 directly targeted and suppressed STAT3 and AChE expression.
  • STAT3 and AChE inhibitors reduced lipopolysaccharide-induced cytokine production.

Conclusions:

  • miR-124 plays a critical role in regulating intestinal macrophage activation.
  • Reduced miR-124 contributes to intestinal inflammation in pediatric IF.
  • miR-124 represents a potential therapeutic strategy for pediatric IF by suppressing inflammation.